Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer

Figure 3

Plasma mSEPT9 for detecting recurrences or metastases in two representative CRC patients during follow-up. (a) Sample number ID: 5. (b) Sample number ID: 14. (a, b) +: positive; −: negative; CEA: ng/mL, boldface represents positive. ; [Calcium levofolinate + tegafur + oxaliplatin] × 4, [calcium levofolinate + tegafur + irinotecan] × 4, [capecitabine + irinotecan] × 3; : intrahepatic, peritoneal, retroperitoneal, and subcutaneous metastases.

(a)

(b)